TSPO and myeloid sarcoma: A 2017 study by Datta et al. [14] also found that MS patients with higher TSPO-PET signal in the normal-appearing white matter (NAWM) exhibited significant greater expansion of T2 hyperintense lesion volume on MRI at one-year follow-up, suggesting TSPO imaging may hold prognostic value for disease progression.